Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase 1 ...
Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited ...
In a paper published in the journal Neuron, researchers report that a mechanism involving the enzyme Tiam1 in dorsal horn excitatory neurons of the spinal cord both initiates and maintains neuropathic ...
In a recent study published in PNAS, researchers investigated the selective activity of sigmoid 2 receptor (σ2R) or transmembrane protein 97 (TMEM97) ligands on murine neuropathic pain models, their ...
Quiver Bioscience wins NIH HEAL grant to advance QV-2421, its Nav1.7 ASO therapy for chronic neuropathic pain, toward human trials.
Neuropathic pain in individuals with cancer remains a challenging clinical problem that requires advanced pharmacologic skills and a clear understanding of the molecular mechanisms that drive it. At ...
A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study ...
How can patients and clinicians effectively manage diabetic neuropathic pain in 2024? At the French Diabetes Society congress, three experts provided a comprehensive overview of the treatment for ...
Morning Overview on MSN
Scientists uncover why chronic pain persists — a tiny region called the caudal granular insular cortex holds the answer
A light brush of fabric against skin should not cause agony. But for the roughly 51 million American adults living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results